Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
If Americans during President Donald Trump’s first term were exhausted by his “controversy and chaos,” they now appear to be similarly distressed by his “backtracking and blowing things up,” according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results